Wearable electronic devices such as smart watches, worn by consumers to monitor their health, could interfere with the correct working of cardiac implantable electronic devices (CIEDs), posing serious ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

In today’s world we have come to rely on our devices, such as smartphones, tablets and laptops, as a key element in all aspects of our lives. Whether it’s letting loved ones know we’re on our way, ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. An implantable device that shocks an erratically beating heart back into ...

Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...

DUBLIN--(BUSINESS WIRE)--The "Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report ...

The vast majority of Medicare beneficiaries with infection of a cardiac implanted electronic device (CIED) don’t have their hardware removed within 30 days, contrary to guideline recommendations, and ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...

A widely anticipated heart disease study released Tuesday could boost the use of an advanced type of heart defibrillator made by companies with strong roots in Minnesota. The 1,820-patient study -- ...